POZZI, ERNESTO
 Distribuzione geografica
Continente #
NA - Nord America 2.494
AS - Asia 1.938
EU - Europa 1.658
SA - Sud America 212
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.405
Nazione #
US - Stati Uniti d'America 2.436
CN - Cina 1.013
SG - Singapore 407
IE - Irlanda 357
UA - Ucraina 264
DE - Germania 228
FI - Finlandia 190
HK - Hong Kong 189
BR - Brasile 168
RU - Federazione Russa 152
VN - Vietnam 142
FR - Francia 108
GB - Regno Unito 87
SE - Svezia 86
ZA - Sudafrica 78
IT - Italia 75
IN - India 39
CA - Canada 30
BD - Bangladesh 28
NL - Olanda 24
BE - Belgio 17
IQ - Iraq 17
MX - Messico 17
PL - Polonia 17
JP - Giappone 15
ES - Italia 13
EC - Ecuador 12
TR - Turchia 11
AR - Argentina 10
AT - Austria 10
CO - Colombia 9
PK - Pakistan 8
KR - Corea 7
CZ - Repubblica Ceca 6
ID - Indonesia 6
MA - Marocco 6
SA - Arabia Saudita 6
TN - Tunisia 6
UZ - Uzbekistan 6
IR - Iran 5
LT - Lituania 5
OM - Oman 5
CL - Cile 4
EG - Egitto 4
MK - Macedonia 4
MY - Malesia 4
PH - Filippine 4
PY - Paraguay 4
AZ - Azerbaigian 3
ET - Etiopia 3
GR - Grecia 3
HR - Croazia 3
TH - Thailandia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
RO - Romania 2
SV - El Salvador 2
TJ - Tagikistan 2
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 6.405
Città #
Dublin 357
Chandler 319
Jacksonville 313
Ashburn 243
San Jose 236
Nanjing 215
Singapore 201
Hong Kong 180
Beijing 170
Dallas 114
Boardman 103
Nanchang 82
Johannesburg 74
Shenyang 64
Lawrence 61
Princeton 61
Hebei 57
Helsinki 57
Los Angeles 57
Ann Arbor 55
Wilmington 55
Jiaxing 54
Lauterbourg 52
Piscataway 47
Shanghai 47
Changsha 45
Hangzhou 40
Ho Chi Minh City 39
Medford 39
New York 37
Hanoi 33
Moscow 31
Woodbridge 28
Tianjin 27
Buffalo 26
Milan 26
Munich 25
Council Bluffs 23
Orem 21
Paris 18
Verona 18
Tokyo 15
Brussels 14
Redondo Beach 14
Santa Clara 13
The Dalles 13
Toronto 13
Kunming 12
Seattle 12
Warsaw 12
Brooklyn 11
Fairfield 11
São Paulo 11
Turku 10
Atlanta 8
Baghdad 8
Belo Horizonte 8
London 8
Passau 8
Phoenix 8
Columbus 7
Des Moines 7
Frankfurt am Main 7
Haiphong 7
Hyderabad 7
Montreal 7
Norwalk 7
Stockholm 7
Zhengzhou 7
Boston 6
Chicago 6
Dearborn 6
Denver 6
Hải Dương 6
Tappahannock 6
Tashkent 6
Washington 6
Berlin 5
Da Nang 5
Guangzhou 5
Houston 5
Jinan 5
Jining 5
Mexico City 5
Mumbai 5
Ningbo 5
Prague 5
Rome 5
San Francisco 5
Amsterdam 4
Charlotte 4
Chennai 4
Falls Church 4
Guayaquil 4
Hanover 4
Madrid 4
Ninh Bình 4
Nuremberg 4
Poplar 4
Pune 4
Totale 4.174
Nome #
Biomedical and functional changes in bronchoalveolar parameters induced by ambroxol treatment of chronic bronchitis 407
Bronchoalveolar Lavage Fluid Proteome in Bronchiolitis Obliterans Syndrome: Possible Role for Surfactant Protein A in Disease Onset 155
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 150
"Nonobstructive" emphysema of the lung 137
Familial elevation of serum angiotensin converting enzyme activity. 132
Assessment of emphysema in COPD. A functional and radiologic study 130
Long-term effects of pulmonary andoarterectomy on cardioplmonary function and exercise tolerance 130
The frequency of Interleukin-10 and Interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted Lung 129
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 129
Chronic productive cough in young adults is very often due to chronic rhino-sinusitis 126
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 126
Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. 123
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 121
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 119
Expression of receptor for advanced glycation end products in sarcoid granulomas. 118
Ambroxol and pulmonary toxicity induced by antineoplastic drugs. 117
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. 116
Studies of MR 889, a new synthetic proteinase inhibitor. 116
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 114
Acebrophylline: an airway mucoregulator and anti-inflammatory agent. 114
Long-term outcome after pulmonary endarterectomy. 114
Depression after lung transplantation: causes and treatment 113
Emergence of new pneumonia: besides severe acute respiratory syndrome 110
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 109
Dai chinoloni ai fluorochinoloni respiratori 108
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 108
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 105
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. 102
The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. 101
PERCUTANEOUS COMPUTED TOMOGRAPHY-GUIDED RADIOFREQUENCY THERMAL ABLATION OF SMALL UNRESECTABLE LUNG TUMOURS. 100
Nod2/CARD15 gene polymorphism in idiopathic pulmonary fibrosis 97
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study. 97
Alpha 1-antitrypsin variants produced by recombinant DNA: differences in elastase inhibitory activity and resistance to oxidant agents. 96
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 95
Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. 93
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study. 92
Long-term clinical and cardiopulmonary effects of pulmonary endarteriectomy (PEA) 91
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. 91
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection 88
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. 87
Long-term outcome after pulmonary endarterectomy 86
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome 84
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. 82
What defines airflow obstruction in asthma? 81
RAGE receptor: a novel pro-inflammatory pathway for chronic respiratory disorders? 80
In vivo studies of rat alveolar macrophage [corrected] microviscosity: influence of pulmonary surfactant synthesis stimulation. 80
Followup a lungo termine di pazienti affetti da ieprtensione polmonare cronica tromboembolica sottoposti ad endoarteriectomia polmonare 79
Primary lung adenocarcinoma: characteristics by smoking habit and sex. 79
SP-A binds alpha1-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase. 78
Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies. 78
NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. 77
Targeting EGFR in non-small-cell lung cancer: Lessons, experiences, strategies. 75
Role of alveolar phospholipids in bleomycin-induced pulmonary fibrosis in the rat. 72
Long-term effects of pulmonary endarterectomy (PEA) on clinical and cardiopulmonary function status 71
Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency 70
Plasmapheresis for treatment of pulmonary alveolar proteinosis. 69
Synchronous lung cancers: when same histological types feature different molecular profiles and response phenotypes. 67
Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. 65
Relationship between changes in alveolar surfactant levels and lung defence mechanisms. 65
Interstitial pneumopathy and low-dosage amiodarone. 57
Sputum levels of eriythromycin after rectal administration in adult patients with bronchitis. 53
Complement receptor 1 gene polymorphisms in sarcoidosis. 49
null 33
Totale 6.436
Categoria #
all - tutte 25.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022253 10 3 8 3 7 6 7 17 15 5 46 126
2022/2023951 109 72 10 77 102 94 1 49 411 6 15 5
2023/2024409 47 70 10 18 42 83 3 52 4 16 55 9
2024/2025908 40 67 19 38 9 45 79 85 213 25 86 202
2025/20262.024 168 152 201 173 256 111 409 121 172 165 53 43
Totale 6.436